Cetera Advisors LLC Dexcom Inc Transaction History

Cetera Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$114.22 - $140.1 $3.99 Million - $4.89 Million	34,923 Added 593.42%	40,808 $5.66 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $19,702 - $32,405	261 Added 4.64%	5,885 $730,000
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $34,940 - $55,999	-406 Reduced 6.73%	5,624 $524,000
Q2 2023 Aug 09, 2023	BUY	$112.47 - $130.98 $15,183 - $17,682	135 Added 2.29%	6,030 $774,000
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $32,656 - $38,596	-314 Reduced 5.06%	5,895 $684,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $527,640 - $761,658	6,209 New	6,209 $703,000
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $48,181 - $60,406	-371 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$106.71 - $143.18 $39,589 - $53,119	371 New	371 $203,000
Q4 2020 Feb 17, 2021	SELL	$78.0 - $104.5 $39,156 - $52,459	-502 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $27,984 - $33,094	-293 Reduced 36.86%	502 $207,000
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $49,830 - $83,745	795 New	795 $322,000
Q2 2019 Aug 12, 2019	SELL	$27.84 - $38.92 $102,061 - $142,680	-3,666 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$28.07 - $38.18 $102,904 - $139,967	3,666 New	3,666 $436,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.